Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D.
Bruna R KoubaAnderson CamargoAna Lúcia S RodriguesPublished in: Metabolic brain disease (2023)
Alzheimer's disease (AD) is the most common cause of dementia. In recent years, several studies have robustly shown that neuroinflammation plays a crucial role in the pathophysiology of this disease. The co-localization of amyloid-β plaques near activated glial cells and the increased levels of inflammatory cytokines in AD patients indicate the involvement of the neuroinflammatory process in AD progression. Considering that pharmacological treatment remains a challenge for the management of this disease, compounds with anti-inflammatory and antioxidant properties are promising therapeutic strategies. In this context, vitamin D has gained attention in the last few years due to its neuroprotective property and the high prevalence of vitamin D deficiency in the population. Herein, in this narrative review we present the possible contribution of the antioxidant and anti-inflammatory properties of vitamin D for its neuroprotective effects, and the clinical and preclinical data dealing with the effects of vitamin D in AD, focusing mainly on the neuroinflammatory process.
Keyphrases
- anti inflammatory
- end stage renal disease
- cognitive impairment
- newly diagnosed
- cognitive decline
- lps induced
- ejection fraction
- induced apoptosis
- risk assessment
- stem cells
- cell proliferation
- spinal cord injury
- inflammatory response
- peritoneal dialysis
- neuropathic pain
- electronic health record
- prognostic factors
- cell death
- cell cycle arrest
- spinal cord
- blood brain barrier